Magnitude 7.9 Quake Cut into Simcere Pharmaceutical’s First-half Earnings; Company “Very Close” To First Round Of Acquistions

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.